Related Experiment Video
Updated: Jul 2, 2025

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitis
Ji-Hyun Lee1,2, Seung Hoon Lee3, Chanhyeok Jeon3
1Department of Rheumatology, Eulji Rheumatology Research Institute, Eulji University School of Medicine, 712 Dongil-Ro, Uijeongbu, Gyeonggi-Do, 11759, Republic of Korea.
Complement factor H-related protein-5 (CFHR5) is elevated in ankylosing spondylitis (AS) and exacerbates pathological bone formation. Targeting CFHR5 may offer a new therapeutic strategy for AS patients.
Area of Science:
- Rheumatology
- Immunology
- Bone Biology
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease marked by excessive new bone formation.
- Complement factor H-related protein-5 (CFHR5) is elevated in AS patients.
- The role of CFHR5 in AS pathogenesis, particularly new bone formation, is not fully understood.
Purpose of the Study:
- To investigate the role of CFHR5 in the pathological bone formation associated with ankylosing spondylitis.
- To explore the relationship between CFHR5, proinflammatory cytokines, and C-reactive protein (CRP) in AS.
- To determine the effect of CFHR5 on osteoprogenitors and ectopic bone formation in AS models.
Main Methods:
- Quantified serum levels of CFHR5 and proinflammatory cytokines (TNF, IL-6, IL-17A, IL-23) in AS patients and healthy controls (HC).
- Analyzed correlations between CFHR5, cytokines, and CRP.
- Administered recombinant CFHR5 in a mouse model of AS (curdlan-injected SKG) and assessed bone formation via micro-CT.
- Examined CFHR5 expression in AS-derived osteoprogenitors and its effect on osteogenic differentiation and mineralization in vitro, including MMP13 expression.
Main Results:
- CFHR5 and proinflammatory cytokines were elevated in AS patients compared to HC.
- CFHR5 levels positively correlated with high CRP but not significantly with proinflammatory cytokines in AS.
- In vivo, CFHR5 treatment increased ectopic bone formation in the ankle joints of AS model mice.
- In vitro, CFHR5 upregulated basal expression in AS-osteoprogenitors and enhanced bone mineralization during osteogenic differentiation, accompanied by increased MMP13 expression.
Conclusions:
- CFHR5 is upregulated in AS and contributes to pathological bone formation.
- CFHR5 exacerbates ectopic bone formation and enhances osteoprogenitor mineralization in AS.
- Therapeutic targeting of CFHR5 presents a potential strategy for treating ankylosing spondylitis.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Regulation of Hematopoietic Stem Cells

